TSS
NMTC icon

Two Sigma Securities’s NeuroOne Medical Technologies NMTC Stock Holding History

Two Sigma Securities’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.2K Buy
+4,127
New +$19.8K ﹤0.01% 1375
2025
Q4 		– Sell
-2,060
Closed -$11K – 1841
2025
Q3 		$11K Buy
+2,060
New +$10.1K ﹤0.01% 1211
2024
Q2 		– Sell
-1,885
Closed -$13.6K – 3434
2024
Q1 		$13.6K Buy
+1,885
New +$14.3K ﹤0.01% 2724

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Two Sigma Securities's NMTC Position: Q1 2026 in Review

Two Sigma Securities opened a new position in NeuroOne Medical Technologies (NMTC) in Q1 2026: 4,127 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NMTC as recently as Q3 2025.

Two Sigma Securities first reported a position in NMTC in Q1 2024 and has held it in 3 quarters since. 32 funds tracked by Wall St. Rank hold NMTC as of Q1 2026.

  • Two Sigma Securities held 4,127 shares of NeuroOne Medical Technologies worth $19.2K as of Q1 2026.
  • NeuroOne Medical Technologies was a new Two Sigma Securities position in Q1 2026.
  • NeuroOne Medical Technologies made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1375 holding.
  • Two Sigma Securities first reported a position in NeuroOne Medical Technologies in Q1 2024 and has held it in 3 quarters since.
  • 32 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.